US FDA completes inspection at Unit V of Apitoria Pharma Private Limited

The United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufacturing facility, of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company, situated at Pashamylaram Village, Patancheru Mandal, Sanga Reddy District, Telangana from December 09 to December 17, 2024.

The inspection closed with 02 observations. The observations are of procedural in nature and will be responded to within the stipulated time.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1245.00 as compared to the previous close of Rs. 1207.95. The total number of shares traded during the day was 14113 in over 1622 trades.

The stock hit an intraday high of Rs. 1247.95 and intraday low of 1220.45. The net turnover during the day was Rs. 17417971.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 ApitoriaPharma USFDA Inspection UnitV 2Observations